Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
T0L2WNpZZ8nDkaTR
